RB1 Polyclonal antibody 10048-2-Ig proteintech

$149.00
In stock
SKU
10048-2-Ig
Catalog No.SizePrice (USD)
10048-2-IG-20UL20 μL$149.00
10048-2-IG-150UL150 μL$449.00
Catalog Number10048-2-Ig
Synonymsp105 Rb, p105-Rb, p110-RB1, p110-RB1 , pp110
HostRabbit
Reactivityhuman and More (1)
Reactivityhuman, zebrafish
FormLiquid
FormulationPBS, Azide, Glycerol
ApplicationsWB, IHC, IF/ICC, IP, CoIP, ELISA
ApplicationsWB, IHC, IF/ICC, IP, ELISA
Host / IsotypeRabbit / IgG
Tested Applications — Positive WB detected inA431 cells, Calyculin A treated Jurkat cells, MCF-7 cells
Tested Applications — Positive IP detected inA431 cells
Tested Applications — Positive IHC detected inhuman intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Tested Applications — Positive IF/ICC detected inhTERT-RPE1 cells
Recommended Dilutions — Western Blot (WB)WB : 1:5000-1:50000
Recommended Dilutions — Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Recommended Dilutions — Immunohistochemistry (IHC)IHC : 1:200-1:800
Recommended Dilutions — Immunofluorescence (IF)/ICCIF/ICC : 1:400-1:1600
Positive WB detected inA431 cells, Calyculin A treated Jurkat cells, MCF-7 cells
Positive IP detected inA431 cells
Positive IHC detected inhuman intrahepatic cholangiocarcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inhTERT-RPE1 cells
Western Blot (WB)WB : 1:5000-1:50000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:200-1:800
Immunofluorescence (IF)/ICCIF/ICC : 1:400-1:1600
Tested Reactivityhuman
Cited Reactivityhuman, zebrafish
ClassPolyclonal
TypeAntibody
ImmunogenCatNo: Ag0006 Product name: Recombinant human RB1 protein Source: e coli. -derived, Unknow Tag: N/A Domain: Gst-Rb1-928 of BC040540 Sequence: Predict reactive species
Full Nameretinoblastoma 1
Calculated Molecular Weight110 kDa
Observed Molecular Weight110 kDa
GenBank Accession NumberBC040540
Gene SymbolRB1
Gene ID (NCBI)5925
RRIDAB_2177320
ConjugateUnconjugated
Purification MethodProtein A purification
UNIPROT IDP06400
Storage BufferPBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA.
IF protocol for RB1 antibody 10048-2-IgDownload protocol
IHC protocol for RB1 antibody 10048-2-IgDownload protocol
IP protocol for RB1 antibody 10048-2-IgDownload protocol
WB protocol for RB1 antibody 10048-2-IgDownload protocol
humanWB Theranostics Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation. Authors - Shuai Huang View Article
Georgina (Verified Customer) (07-04-2022)This antibody gave some background staining, however the band of interest was clear. Applications: Western Blot Primary Antibody Dilution: 1 in 5000 Cell Tissue Type: Human HepG2 cells
Kyle (Verified Customer) (12-04-2018)Applications: Western Blot, Primary Antibody Dilution: 1:1000 Cell Tissue Type: small cell lung cancer
Citations89
DilutionsWB : 1:5000-1:50000 IP : 0.5-4.0 ug for IP and 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate for WB IHC : 1:200-1:800 IF/ICC : 1:400-1:1600
IsotypeIgG
ClonalityPolyclonal
Clone Number-
ConjugationUnconjugated

RB1, also named as pp110, pRb and p105 Rb, belongs to the retinoblastoma protein (RB) family. It is a key regulator of entry into cell division that acts as a tumor suppressor. RB1 acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. It is directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. It recruits and targets histone methyltransferases SUV39H1, SUV420H1 and SUV420H2, leading to epigenetic transcriptional repression. RB1 controls histone H4 'Lys-20' trimethylation and inhibits the intrinsic kinase activity of TAF1. It mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. This antibody is a rabbit polyclonal antibody raised against human RB1 fusion protein. Protocols Product Specific Protocols IF protocol for RB1 antibody 10048-2-Ig Download protocol IHC protocol for RB1 antibody 10048-2-Ig Download protocol IP protocol for RB1 antibody 10048-2-Ig Download protocol WB protocol for RB1 antibody 10048-2-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Publications

  1. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
    Journal: Nat Genet | Authors: Wang Guocan G | Application: IHC
  2. Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.
    Journal: Gastroenterology | Authors: Yuhong Luo | Species: human | Application: IHC
  3. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Journal: J Clin Invest | Authors: Zheng Hu | Species: human | Application: WB,IHC
  4. Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
    Journal: Nat Commun | Authors: Kai Yuan | Species: human | Application: WB
  5. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo
    Journal: Front Med | Authors: Bo Li | Species: human | Application: WB
  6. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation.
    Journal: Theranostics | Authors: Shuai Huang | Species: human | Application: WB
  7. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
    Journal: Nat Genet | Authors: Wang Guocan G | Application: IHC
  8. CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
    Journal: Cancer Res | Authors: Wei Li | Species: human | Application: WB
  9. Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
    Journal: Nat Commun | Authors: Kai Yuan | Species: human | Application: WB
  10. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation.
    Journal: Theranostics | Authors: Shuai Huang | Species: human | Application: WB
  11. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Journal: J Clin Invest | Authors: Zheng Hu | Species: human | Application: WB,IHC
  12. Phytosphingosine Alleviates Cigarette Smoke-Induced Bronchial Epithelial Cell Senescence in Chronic Obstructive Pulmonary Disease by Targeting the Free Fatty Acid Receptor 4.
    Journal: MedComm (2020) | Authors: Yuan Zhan | Species: mouse,human | Application: WB,IP,IHC,IF
  13. Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function
    Journal: Cell Death Differ | Authors: Xiang Jiang | Species: human | Application: WB
  14. Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer
    Journal: Cell Death Differ | Authors: Da Ren | Species: human | Application: WB
  15. Bioswitchable intracellular delivery of small activating RNA by tetrahedral framework nucleic acid: Application to p21-mediated anti-tumor therapy.
    Journal: J Control Release | Authors: Yuhao Liu | Species: human | Application: WB
  16. Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.
    Journal: Mol Ther | Authors: Da Zhu | Species: human | Application: WB,IF
  17. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV 16/18-positive cervical cancer cells.
    Journal: Clin Cancer Res | Authors: Wencheng Ding | Species: human | Application: WB
  18. circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis
    Journal: Acta Pharmacol Sin | Authors: Hua-Yan Wu | Application: WB
  19. LDHC4 drives lung adenocarcinoma progression by inducing lactylation of RB1 at lysine 900 to disrupt the RB1-E2F1 complex.
    Journal: J Transl Med | Authors: Wei Peng | Species: human | Application: WB
  20. Loss of RanGAP1 drives chromosome instability and rapid tumorigenesis of osteosarcoma
    Journal: Dev Cell | Authors: Yan Gong | Application: WB
  21. Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAFV600E-induced growth arrest in melanocytes
    Journal: Oncogene | Authors: Kimberley McGrail | Application: WB
  22. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Journal: Oncogene | Authors: Xisheng Yang | Species: human | Application: WB
  23. CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.
    Journal: Oncogene | Authors: Q Tu | Application: IF
  24. Identification and functional analysis of 9p24 amplified genes in human breast cancer.
    Journal: Oncogene | Authors: Wu J J | Species: human | Application: WB
  25. E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
    Journal: Int J Nanomedicine | Authors: Jinfeng Xiong | Application: IHC
  26. Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4/CDK6-RB1 axis in vitro and in vivo
    Journal: Front Med | Authors: Bo Li | Species: human | Application: WB
  27. Diet-metabolism-transcription axis modulates the sensitivity to CDK4/6 inhibitors through RB1 in prostate cancer.
    Journal: Cell Rep | Authors: Xurui Li | Species: human | Application: WB
  28. Molecular basis of the HPV E7-ZER1 axis reveals a ligandable vulnerability in HPV-positive cancers.
    Journal: Cell Rep | Authors: Xiaolu Wang
  29. LncRNA H19-Encoded Micropeptide altH19 Promotes DNA Replication and Mitosis in Myeloma Cells by Enhancing the Phosphorylation of CDK2 at Threonine 160.
    Journal: Cell Prolif | Authors: Yaxin Zhang | Species: human | Application: WB
  30. Transcription factor zinc fingers and homeoboxes protein 2 (ZHX2) drives CRABP1 targeting to strengthen retinoic acid sensitivity and potentiate therapeutic response in neuroblastoma.
    Journal: Biomed Pharmacother | Authors: Yan Wang | Species: human | Application: WB
  31. Talaketides A-G, linear polyketides with prostate cancer cytotoxic activity from the mangrove sediment-derived fungus Talaromyces sp. SCSIO 41027
    Journal: Chin J Nat Med | Authors: Chunmei Chen | Species: human
  32. Discover of a highly effective covalent inhibitor of CDK6 for triple-negative breast cancer treatment.
    Journal: Eur J Med Chem | Authors: Jingting Zeng
  33. Discovery of potent and selective CDK2 inhibitors with high safety and favorable bioavailability for the treatment of cancer
    Journal: Eur J Med Chem | Authors: Weijiao Chen | Species: human | Application: WB
  34. Ribociclib mitigates cisplatin-associated kidney injury through retinoblastoma-1 dependent mechanisms.
    Journal: Biochem Pharmacol | Authors: Ji Young Kim | Application: WB
  35. The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.
    Journal: Cancer Gene Ther | Authors: Faming Wang | Species: human | Application: WB
  36. The application of CRISPR/Cas9 system in cervical carcinogenesis.
    Journal: Cancer Gene Ther | Authors: Chun Gao | Species: human | Application: WB,IHC
  37. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Journal: Oncotarget | Authors: Ge Qin | Species: human | Application: WB
  38. Inhibition of Senescence-Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post-Myocardial Infarction.
    Journal: J Am Heart Assoc | Authors: Perwez Alam | Application: WB
  39. ASIC1 and ASIC3 mediate cellular senescence of human nucleus pulposus mesenchymal stem cells during intervertebral disc degeneration.
    Journal: Aging (Albany NY) | Authors: Jingyu Ding | Species: human | Application: WB
  40. Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility.
    Journal: Gene Ther | Authors: G Ian Gallicano | Species: human | Application: WB,IF
  41. Senescent endothelial cell-derived extracellular vesicles promote neoadjuvant chemoresistance in colorectal cancer via GPX4.
    Journal: Commun Biol | Authors: Kunpeng Jia | Species: human | Application: WB,IHC,IF
  42. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells.
    Journal: Int J Mol Sci | Authors: Chen Chen | Species: human | Application: WB
  43. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.
    Journal: Artif Cells Nanomed Biotechnol | Authors: Tianqi Li | Species: human | Application: IF
  44. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
    Journal: Cancer | Authors: Zhang Jianjun J | Species: human | Application: WB
  45. Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions.
    Journal: Front Pharmacol | Authors: Jinfeng Xiong | Application: IHC
  46. Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development
    Journal: Front Pharmacol | Authors: Ying Luo | Species: human | Application: WB
  47. Analysis of regulating activities of 5'-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo
    Journal: Front Pharmacol | Authors: Xueni Wang | Species: human | Application: WB
  48. Synthesis and evaluation of novel N-arylamide-quinoline derivatives as HDAC isoform-selective inhibitors: in vitro and in vivo anticancer efficacy and pharmacokinetic studies.
    Journal: Bioorg Chem | Authors: Bingyan Yu | Species: human | Application: WB
  49. Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC.
    Journal: Bioorg Chem | Authors: Yiling Lai | Species: human | Application: WB
  50. The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.
    Journal: Oncotarget | Authors: Lifei Fan | Species: human | Application: WB
  51. Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells.
    Journal: Sci Rep | Authors: Zheyong Liang | Species: human | Application: WB,IHC
  52. MKRN2-Mediated Degradation of IGF2BP3 Suppresses MYC and Enhances CDK4/6 Inhibitor Sensitivity in Bladder Cancer.
    Journal: Cancers (Basel) | Authors: Qi Pan
  53. FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA
    Journal: Neoplasia | Authors: Qingliu He
  54. Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells
    Journal: Cancers (Basel) | Authors: Shraddha Bhutkar | Species: human | Application: WB
  55. SERPINF1 knockdown attenuates chondrocyte senescence, hypertrophy, and inflammation in osteoarthritis to offer a potential therapeutic strategy
    Journal: Cell Signal | Authors: Lini Dong | Species: human | Application: WB
  56. Knockout of mafba Causes Inner-Ear Developmental Defects in Zebrafish via the Impairment of Proliferation and Differentiation of Ionocyte Progenitor Cells.
    Journal: Biomedicines | Authors: Xiang Chen | Species: zebrafish | Application: WB
  57. Icaritin inhibits CDK2 expression and activity to interfere with tumor progression
    Journal: iScience | Authors: Chao Zhang | Species: human | Application: WB,CoIP
  58. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Journal: Antiviral Res | Authors: Yili Chen | Species: human | Application: WB
  59. The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer
    Journal: Antiviral Res | Authors: Zongfeng Hu | Species: human | Application: WB
  60. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1
    Journal: J Biol Chem | Authors: Neng Li | Species: human | Application: WB,IP
  61. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1
    Journal: J Biol Chem | Authors: Neng Li | Species: human | Application: WB,IP
  62. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D.
    Journal: J Biol Chem | Authors: Zang Yi Y | Application: WB
  63. A novel piperine derivative HJ-23 exhibits anti-colorectal cancer effects by activating the p53 pathway
    Journal: Naunyn Schmiedebergs Arch Pharmacol | Authors: Meiqi Zhang | Species: human | Application: WB
  64. Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
    Journal: J Endocrinol Invest | Authors: Y Huo | Application: WB
  65. FAIM-S functions as a negative regulator of NF-κB pathway and blocks cell cycle progression in NSCLC cells.
    Journal: Cell Cycle | Authors: Pengcheng Wang | Species: human | Application: WB
  66. CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan
    Journal: Cell Cycle | Authors: Joshua Blume | Application: WB
  67. A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.
    Journal: Cell Cycle | Authors: Yanan Wang | Species: human | Application: WB
  68. USP53 activated by H3K27 acetylation regulates cell viability, apoptosis, and metabolism in esophageal carcinoma via the AMPK signaling pathway.
    Journal: Carcinogenesis | Authors: Wei Cheng | Species: human | Application: IHC
  69. PABPN1 Promotes clear cell Renal Cell Carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1
    Journal: Carcinogenesis | Authors: Ming Xiong | Species: human | Application: WB
  70. Methionine aminopeptidase 1D preserves myogenic cell integrity via maintaining mitochondrial activity.
    Journal: Exp Cell Res | Authors: Cheng-Ta Tsai | Application: WB
  71. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
    Journal: Biomed Pharmacother | Authors: Yudi Xiong | Species: human | Application: IHC
  72. Case Report: A novel germline donor splicing site mutation of RB1 gene in a Chinese Tibetan pedigree with familial retinoblastoma
    Journal: Front Oncol | Authors: Guo-Qian He | Species: human | Application: IHC
  73. Mechanisms underlying the therapeutic effects of Amygdalin in treating Cervical Cancer based on multi-omics analysis.
    Journal: J Pharm Biomed Anal | Authors: Qianqian Jiang | Species: human | Application: WB
  74. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
    Journal: Front Oncol | Authors: Biao Xie | Species: human | Application: IHC
  75. Bioinformatics analysis combined with experiments to verify potential autophagy genes in wound healing.
    Journal: Ann Transl Med | Authors: Yong-Fang Wu | Species: human | Application: WB
  76. SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease.
    Journal: Front Neurol | Authors: Xuan Li | Species: human | Application: WB
  77. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
    Journal: FEBS Lett | Authors: Sun Fang F | Species: human | Application: WB
  78. Targeting DUSP3 promotes cell senescence by activating the notch1 pathway to treat hepatocellular carcinoma
    Journal: Tissue Cell | Authors: Wen-Jun Zhang | Species: human | Application: WB
  79. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
    Journal: FEBS Lett | Authors: Sun Fang F | Species: human | Application: WB
  80. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
    Journal: Mol Pharmacol | Authors: Hsu Tsung-I TI | Species: human | Application: WB
  81. Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells.
    Journal: Biomed Res Int | Authors: Zheng Hu | Species: human | Application: WB
  82. Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts.
    Journal: PLoS One | Authors: David I Brown | Application: WB
  83. Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation.
    Journal: PLoS One | Authors: Xiu Shan | Application: WB
  84. Tumor Prostate-Specific Antigen Density Can Predict Tumor Aggressiveness and Heterogeneity in Prostate Cancer.
    Journal: Prostate | Authors: Tao Yang | Species: human | Application: IHC
  85. Exploration of Therapeutic Targets Using CDK4 Inhibitors for Head and Neck Mucosal Melanoma.
    Journal: Otolaryngol Head Neck Surg | Authors: Takayoshi Hattori | Species: human | Application: WB
  86. N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis
    Journal: Drugs R D | Authors: Wenping Guo | Species: human | Application: WB
  87. HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.
    Journal: Onco Targets Ther | Authors: Qinghua Wang | Species: human | Application: WB
  88. Effect of exogenous p16ink4a and hRb1 genes on cell cycle regulation of osteosarcoma cell.
    Journal: J Huazhong Univ Sci Technolog Med Sci | Authors: Liao Xiang X | Species: human | Application: WB
  89. RNA-binding protein THUMPD2 inhibits proliferation and promotes metastasis in epithelial ovarian cancer
    Journal: Heliyon | Authors: Minhui Hua | Species: human | Application: WB

Reviews

Write Your Own Review
You're reviewing:RB1 Polyclonal antibody 10048-2-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.